Sommaire

• • ·How can basic scientific research contribute to tuberculosis programmes?

    Page :1

    S. Cole

    
• • ·Dealing with established drug resistance

    Page :1

    S.J. Kim

    
• • ·Prevention of drug resistant tuberculosis

    Page :1-2

    Lambregts-van Weezenbeek

    
• • ·Asthma among farmers

    Page :2

    Q.T. Pham, N. Chau, S.E. Megherbi, M. Damel, V. Drouinneaud, E. Bourgkard, D. Teculescu

    
• • ·The wheezy child — is it pneumonia?

    Page :2

    K. Mulholland

    
• • ·Benefits of early use of inhaled corticosteroids (ICS)

    Page :2

    A.J. Woolcock

    
• • ·The case against early steroid use

    Page :2-3

    E. Weinberg

    
• • ·Controversies in tuberculosis control: thioacetazone may be used routinely — pro

    Page :3

    L. Rieder Hans

    
• • ·Thiacetazone should not be used routinely — or primum non nocere

    Page :3

    P. Nunn

    
• • ·In favour of immunotherapy with Mycobacterium vaccae

    Page :3-4

    J.L. Stanford, C.A. Stanford

    
• • ·Preventive therapy is an effective tool in HIV/TB

    Page :4

    R. O'Brien

    
• • ·Extrapulmonary tuberculosis (XPTB) in persons with AIDS

    Page :4

    M.D. Iseman

    
• • ·Value of repeated tuberculin testing in congregate settings

    Page :4

    W.W. Stead

    
• • ·Extrapulmonary disease caused by mycobacteria other than Mycobacterium tuberculosis

    Page :4-5

    R.J. Wallace

    
• • ·Management of mycobacteriosis

    Page :5

    A.M. Patel

    
• • ·The IUATLD and tobacco prevention

    Page :5

    N.E. Billo

    
• • ·Interaction HIV/TB

    Page :5-6

    K.M. De Cock

    
• • ·HIV-associated tuberculosis in Europe

    Page :6

    V. Schwoebel, M.C. Delmas, F. Hamers

    
• • ·A mathematical model for the prediction of the impact of HIV infection on tuberculosis

    Page :6

    M. Schulzer, M.P. Radhamani, S. Grzybowski, E. Mark, J.M. FitzGerald

    
• • ·Tuberculosis and HIV — interventions

    Page :6-7

    L. Rieder Hans

    
• • ·Recognition of ARI in families: constraints to seeking care

    Page :7

    T.E. Tupasi

    
• • ·Chronic airways obstruction: the global epidemic

    Page :7

    A. Gulsvik

    
• • ·Mechanisms of drug resistance

    Page :7

    D.B. Young

    
• • ·Early life origins of CAO

    Page :7

    S.O. Shaheen, D.J.P. Barker

    
• • ·Impact of drug-resistance on TB treatment

    Page :7-8

    M.D. Iseman

    
• • ·Scientific basis for asthma treatment

    Page :8

    T. Clark

    
• • ·Organisation et évaluation de la prise en charge des malades

    Page :8

    N. Aït-Khaled

    
• • ·Redactions de directives techniques pour la prise en charge de l'asthme

    Page :8

    B. Keita, N. Aït-Kahled

    
• • ·The role of cytokines in protection and immunopathology in tuberculosis

    Page :8-9

    G. Kaplan

    
• • ·Retrospective nursing study of patient compliance with tuberculosis therapy

    Page :9-10

    C. Morée

    
• • ·Scientific basis for immunotherapy

    Page :9

    G.A.W. Rook, R. Hernandez-Pando, J.L. Stanford

    
• • ·Immunotherapy applied

    Page :9

    O. Bottasso

    
• • ·Directly observed therapy versus patient responsible therapy for TB in two major metropolitan centers in the United States

    Page :10

    S. Barnes, J. Turner, C. Merrifield, G. Modin

    
• • ·The treatment indicators and public health nurse services in Japan

    Page :10-11

    T. Yamashita, M. Aoki, T. Mori

    
• • ·“RAZ” learns about tuberculosis: a health education package

    Page :11

    A. Draffin Jones, J. MacMorran, J. Riedel, E.S. Hershfield, K. Flamand

    
• • ·ARI prevention — the role of Hib vaccines

    Page :11

    K. Mulholland

    
• • ·Possible bottlenecks in vaccine use

    Page :11

    P. Helena Mäkelä

    
• • ·Maternal immunisation for prevention of pneumonia in young infants

    Page :11-12

    D. Lehmann

    
• • ·The crux, the point of implementation

    Page :12

    D.A. Enarson

    
• • ·Home care: opportunities to strengthen TB control

    Page :12

    E. van Praag

    
• • ·Shared concern: prevention

    Page :12

    R. O'Brien

    
• • ·Antibiotic resistance: does it really matter?

    Page :12-13

    K.P. Klugman

    
• • ·056-PA10 A rapid and inexpensive method based on particle counting immunoassay (PACIA) for screening antituberculosis agents

    Page :13

    J.P. Van Vooren, C. Cambiaso, K. Huygen, E. Serruys, F. Portaels, A. Drowart

    
• • ·113-PA10 Systematic quality control (QC) of sputum bacteriological examinations in the framework of NTBCP in Oyo, Osun States (Nigeria)

    Page :13

    M.P. Valenti, Esq. Olanisebe, J. Osho

    
• • ·119-PA10 Early identification of Mycobacterium bovis by using species-specific monoclonal antibodies in ELISA

    Page :13-14

    K. Lyashchenko, L. Mikhalsky, T. Gots, O. Chatilova

    
• • ·121-PA10 Detection of Mycobacterium tuberculosis in bronchoalveolar lavage samples of suspect tuberculosis cases using polymerase chain reaction

    Page :14

    G. Yilmaz, B. Utku, A.R. Kücükusta, N. Çine, T. Özçelik

    
• • ·122-PA10 Polymerase chain reaction in diagnostic pleural effusions

    Page :14

    G. Yilmaz, B. Utku, A.R. Küçükusta, N. Çine, T. Özçelik

    
• • ·159-PA10 Use of the Gen-Probe transcription mediated amplification system for the direct detection of Mycobacterium tuberculosis in clinical specimens

    Page :14-15

    V. Jonas, C.S. Hill

    
• • ·161-PA10 Epidemiologic interpretation of M. tuberculosis (M. tb) DNA fingerprints

    Page :15

    C.R. Braden, G.L. Templeton

    
• • ·185-PA10 Immunocharacterization of a 66 kD protein of mycobacterium tuberculosis

    Page :15

    R.G. Navalkar, G.D. Rajashri, D. McMurray, B.K. Mahfuz, A.B. Deepashree

    
• • ·203-PA10 Evaluation of a direct probe test for M. tuberculosis complex

    Page :15

    B. Watt, G. Harris, A. Rayner

    
• • ·206-PA10 Réorganisation du réseau de microscopie dans le cadre de la redynamisation du PNT

    Page :15-16

    F. Ba, A.H. Diap, A.B. Gaye, M. Sane, H.L. Rieder

    
• • ·207-PA10 Differentiation of M. africanum and M. bovis strains by monoclonal antibodies

    Page :16

    G. Bretzel, H. Wrede, V. Sticht-Groh

    
• • ·209-PA10 A new laboratory tool for direct screening of Mycobacterium tuberculosis complex in clinical specimens?

    Page :16

    V. Hennaux, M.G. Garrino, H. Nizet, F. Pouthier

    
• • ·211-PA10 QuantiFERON-TB: a new in vitro test for tuberculosis and atypical mycobacterial infection

    Page :16

    J.A. Streeton, S.L. Jones

    
• • ·217-PA10 Molecular and biochemical characterization of immunodominant kDa secreted proteins of Mycobacterium tuberculosis. Potential value for new diagnostic techniques

    Page :16-17

    A. Laqueyrerie, P. Militzer, F. Romain, S. Cole, G. Marchal

    
• • ·255-PA10 Antituberculous antibody establishment in BCG vaccinated children with different sensitivity to tuberculin

    Page :17

    I. Bardisevic̆ien≐, A. Petras̆kait≐

    
• • ·256-PA10 Elevation of serum ceruloplasmin in pulmonary tuberculosis

    Page :17

    B. Milenković, V. Stojc̆ić, O. Djurić

    
• • ·263-PA10 Purification and characterisation of isocitrate dehydrogenase and malate dehydrogenase from Mycobacterium tuberculosis and evaluation of their potential as suitable antigens for serodiagnosis of tuberculosis

    Page :17

    R. Öhman, M. Ridell

    
• • ·281-PA10 Use of rapid DNA fingerprinting of M. tuberculosis isolates for clarification of suspected laboratory cross-contamination and errors

    Page :17-18

    J.T. Crawford, W.R. Butler, C.L. Woodley

    
• • ·282-PA10 Multiplex PCR specific for multidrug-resistant Mycobacterium tuberculosis strain W

    Page :18

    B.B. Plikaytis, J.L. Marden, C.L. Woodley, W.R. Butler, J.T. Crawford, T.M. Shinnick

    
• • ·285-PA10 Preliminary investigation of validity of MGIT for rapid detection of tuberculosis

    Page :18

    M. Casal, J. Gutierrez Aroca

    
• • ·286-PA10 Rapid diagnosis of tuberculosis: evaluation of two PCR tests

    Page :18

    M. Casal, M. Vaquero, J. Gutierrez, E. Alvarez

    
• • ·287-PA10 Evaluation of serological testing for the assessment of M. tuberculosis (M.tb) latent infection

    Page :18-19

    E. Rovatti, M.P. Corradi, M. Amicosante, P.L. Tartoni, A. Ancora, A. Franchi, L. Richeldi, A.M. Cenci, W. Panini, C. Casolari, R. Romagnoli, A.M. Pietrantonlo, F. Novaco, C. Saltini

    
• • ·288-PA10 Anti-PPD and anti-DAT serum antibody markers for the diagnosis of tuberculosis (TB) in the HIV-seropositive (HIV⁺)

    Page :19

    M. Amicosante, A. Cuboni, A. Ancora, L. Monno, E. Girardi, G. Angarano, C. Saltini

    
• • ·295-PA10 Reliability of ELISA in diagnosis of pulmonary tuberculosis

    Page :19

    A. El-Feky, M. Abou Shehatta, A. Khaled, A. El-Morsi, S. Agha, M. Viljanen

    
• • ·313-PA10 Identification of mycobacteria isolates using polymerase chain reaction

    Page :19-20

    A. Bahrmand, B. Bakaev, H. Madani, M. Saifi

    
• • ·336-PA10 Granulocyte chemiluminescence activity in tuberculosis (TB) contacts

    Page :20

    K. Zabuska, H. Niemirowska, A. Ponahajba, E. Skopinska

    
• • ·353-PA10 Evaluation of the specificity of Elisa using antigen A60 for diagnosis of tuberculosis in bronchoalveolar lavage fluid (BALF)

    Page :20

    H. Grubek-Jaworska, P. Droszcz, Z. Zwolska-Kwiek, P. Pirożyński, R. Walkiewicz, W. Droszcz, E. Walajtys-Rode

    
• • ·354-PA10 The value of Nitroblue Tetrazolium reduction test by monocytes isolated from peripheral blood of patients with tuberculosis

    Page :20-21

    A. Dubaniewicz

    
• • ·366-PA10 Gamma delta T cells in the diagnosis and monitoring treatment of pulmonary tuberculosis

    Page :21

    R.M. Mróz, E. Kowal, M. Ossolińska

    
• • ·379-PA10 Improvement of Mycobacterium tuberculosis detection in clinical samples using DNA purified on sephaglas

    Page :21

    M.L. Rossetti, A.R. Moura, S. Jardim, A. Zaha

    
• • ·373-PA10 A new look at old diseases in the tropics: Melioidosis and Mycobacterosis: Cellular immunity, (CI), computerised tomography (CT) and management

    Page :21

    D. Tanphaichitra

    
• • ·388-PA10 PCR in diagnosing of tuberculosis

    Page :21-22

    L. Wolska-Goszka, A. Nowak, K. Szeleżyński, J. Galiński

    
• • ·391-PA10 Humoral immune response against A60 antigen in diagnosis of tuberculosis

    Page :22

    A. Siemińska, D. Ciesielki, K. Szeleżyński, A. Żóttowska

    
• • ·433-PA10 Use of sputum smear in diagnosis of pulmonary tuberculosis in operational conditions in a developing country

    Page :22

    P.G. Suarez, S.T. Ivan, O.C. Jave, C.A. Bonilla, J. Portocarrero, R.L. Canales, E.A. Alarcon, D.C. Velasquez, D.B. Victoria

    
• • ·421-PA10 IS6100 based fingerprinting of mycobacterial isolates from Guinea/Conakry

    Page :22

    G. Bretzel, G. Krommes, O. Sow, D. Harmsen, S. Ney, V. Sticht-Groh

    
• • ·013-PA10 Oxidative metabolism in cells of respiratory pathways of guinea pigs with tuberculosis

    Page :22-23

    G.O. Kaminskaya, R.Y. Abdullaev

    
• • ·107-PA10 Définition de la biocristallographic

    Page :23

    H. Bercy

    
• • ·110-PA10 Phenomenon of Insanov

    Page :23

    A.B. Insanov, F.M. Abdullayev, A.A. Umnyashkin

    
• • ·108-PA10 Ultrasonography (US): a non-invasive method of assessment of the character of pleural effusion (PE)

    Page :23

    J. Gryminski, L. Pawlicka, M. Janowiec, Z. Piasecki

    
• • ·198-PA10 The L-alanine dehydrogenase of M. tuberculosis: overexpression in E. coli, purification and characterization

    Page :23-24

    B. Hutter, M. Singh

    
• • ·216-PA10 Bronchoalveolar lavage and related complications in immunocompromised patients with leukemia or lymphoma and signs of pneumonia

    Page :24

    I.A. Müller, M. Kiworr, R. Genitsariotis, H.U. Kauzcor, W. Aulitzky, J. Lorenz

    
• • ·233-PA10 The mode of chemicals immunomodulating activity detection

    Page :24

    S.S. Ginda, D.O. Sain, T.I. Shinkareva, S.V. Pisarenko

    
• • ·257-PA10 Serum levels of ceruloplasmin in sarcoidosis

    Page :24-25

    B. Milenković, V. Stojćić, O. Djurić

    
• • ·258-PA10 Family Pi phenotypes in a patient with ⍺-1 antitrypsin (⍺-1 AT) Pi ZZ phenotype

    Page :25

    A. Ilic, V. Petrovic, S. Radovanovic, B. Milenkovic

    
• • ·402-PA10 Selection of prediction equation for normal lung function in clinical practice

    Page :25

    Ali Kocabaş, Refik Burgut

    
• • ·386-PA10 Investigation of pulmonary surfactant evacuatory function

    Page :25

    N. Brimkulov, G. Belov

    
• • ·449-PA10 Usefulness of PCR in the detection of M. tuberculosis (M.tb) DNA from formalin fixed paraffin embedded lymph-nodes (FFPEL) among patients HIV(+) or HIV(−)

    Page :26

    A.L. Kritski, G. Bonfim, T. Tupinanbá, C.E. Carvalho, P. DallaRosa, M.H. Saad, A. Castelo

    
• • ·441-PA10 Autoantibody spectrum in tubercolosis

    Page :26

    N. Yastrebova, N. Vaneeva, R. Romanova

    
• • ·457-PA10 Bactec 460 TB (Becton-Dickinson) microbiological diagnostic in childhood tuberculosis

    Page :26

    J. Ziotkowski, E. Kopeć, R. Linke-Koziotek, Z. Zwolska-Kwiek, K. Ceglecka-Tomaszewska

    
• • ·470-PA10 Diagnosis of paediatric TB in Lusaka, does PCR help?

    Page :26-27

    Peter Godfrey-Faussett, Connie Osborne, Lamios Munthali, Grace Kahenya, Yolande Thomasse, Roelanda Jonker

    
• • ·024-PA10 Hereditary predisposition to tuberculosis

    Page :27

    V. Chukanova

    
• • ·044-PA10 The clinical significance of serum middle molecules in patients with pulmonary tuberculosis

    Page :27

    T.P. Maslauskene, T.N. Ivanu-Shkina, A.L. Tarabrin

    
• • ·051-PA10 Tuberculosis diagnosis in General City Hospital

    Page :27

    N. Khmelkova

    
• • ·052-PA10 Value of Ag60 in pleural fluid and serum as diagnostic markers of tuberculous pleurisy

    Page :27-28

    L. Valdés, D. Alvarez, M.V. Martino, J.M. Valle, E. San José, A. Pose, B. Chomón

    
• • ·067-PA10 Pulmonary tuberculosis in diabetic patients

    Page :28

    N.N. Ekim, A. Çilli, G. Güz, M. Arslan

    
• • ·071-PA10 Miliary tuberculosis: Blackburn 1978–93

    Page :28

    L.P. Ormerod

    
• • ·077-PA10 The high TB prevalence in elderly Chinese

    Page :28

    J. Woo, P.D.O. Davies

    
• • ·102-PA10 Hemoptysis in patients with tuberculosis and other pneumological disorders

    Page :28-29

    F Salajka

    
• • ·104-PA10 40 Tuberculosis patients presenting chronic hematogeneous spread

    Page :29

    A. Hazar, M. Yalçin, E. Öztürk, B. Çağlayan, M. Kurutepe

    
• • ·118-PA10 Reasons for delayed sputum culture (SC) conversion in pulmonary tuberculosis (PTB)

    Page :29

    M. Korzeniewska-Kosela, D. Michatowska-Mitczuk, S. Wȩdzicha, L. Pawlicka, M. Miller, J. Kuś

    
• • ·130-PA10 On “PFUO-FORM’ of miliary tuberculosis

    Page :29

    N. Magalif

    
• • ·133-PA10 Characteristics of tuberculosis in autopsy material

    Page :29-30

    Zdravko Kosjerina, Vesna Kosjerina-Oštrić

    
• • ·134-PA10 Morphologic characteristics of bronchial glands in tuberculosis

    Page :30

    Zdravko Kosjerina

    
• • ·137-PA10 Results of different short course chemotherapy regimens under the programme condition of Nepal

    Page :30

    T.M. Shakya

    
• • ·143-PA10 Platelets in pulmonary and pleural tuberculosis

    Page :30

    Z. Kartaloğlu, H. Bilgic, R. Aydilek, K. Cerahoğlu, R. Köylü, E. Kunter

    
• • ·160-PA10 Ultra short-term anti tuberculosis treatment with the fixed drug-combination scheme

    Page :30-31

    J.R. Espinosa

    
• • ·170-PA10 Phenotype d'acetylation de l'INH en Nouvelle Calédonie

    Page :31

    M. Noel, H. Levenes, E. Mancel, Y. Barguil

    
• • ·178-PA10 Tuberculous middle lobe syndrome (TMLS)

    Page :31

    V. Skodric, O. Djuric, T. Radosavljevic, I. Pesic, J. Videnovic, V. Zugic

    
• • ·179-PA10 Mortality of tuberculosis in hospitalized patients today

    Page :32

    V. Skodric, S. Sekulic, T. Radosavljevic, M. Vukcevic, Z. Pavlovic-Popovic

    
• • ·192-PA10 Patient's and doctor's delay in Greek TB patients

    Page :32

    G. Politis, M. Toumbis, G. Zarmbis, J. Anestopoulou, M. Manteou, K. Petrakis

    
• • ·181-PA10 Diagnostic errors in bacteriologically negative tuberculosis

    Page :32

    J. Leowski, M. Miller

    
• • ·201-PA10 Neurofibrome cervical simulant une adénite tuberculeuse calcifiée

    Page :32-33

    M. Toppet, Ch. Frickx, S. Hanquinet, P. Heimann

    
• • ·214-PA10 Mycobacterium tuberculosis does not necessarily mean disease?

    Page :33

    H. Leesik, A. Krüüner, M.-A. Reintam, T. Kummik

    
• • ·226-PA10 Health service delay in diagnosis

    Page :33

    J. Kangangi, D. Kibuga

    
• • ·219-PA10 Tuberculose pulmonaire et diabéte

    Page :33

    A. Snouber, M. Guermaz, N. Mened

    
• • ·229-PA10 Morphology of tuberculous nodules in bronchobiopsies

    Page :33

    Zdravko Kosjerina, Vesna Kosjerina-Oštrić

    
• • ·230-PA10 Size of tuberculous nodules in bronchial structures

    Page :34

    Zdravko Kosjerina

    
• • ·243-PA10 Specific pericarditis as the first manifestation of the generalized miliary tuberculosis — case report

    Page :34

    J. Kunosic, V. Kacar, N. Vasic, G. Radosavljevic, Lj. Nagomi-Obradovic, N. Bogdanovic

    
• • ·242-PA10 Atypic localisation of pulmonary tuberculosis

    Page :34

    Z. Lazić, V. Petrović, S. Radovanović, O. Gajović

    
• • ·231-PA10 Tuberculosis of the trachea — a tumorous form

    Page :34

    Vesna Kosjerina-Oštrić, Zdravko Kosjerina

    
• • ·245-PA10 Pleural effusion of tuberculous etiology

    Page :34-35

    Lj. Nagomi-Obradovic, V. Bosnjak-Petrovic, V. Cemerikic, J. Kunosic, N. Mujovic

    
• • ·266-PA10 Diagnosis of pulmonary tuberculosis: criteria and their implications for assessing outcome of tuberculosis

    Page :35

    J.R. Glynn, P.E.M. Fine, J.M. Pönnighaus, D.K. Warndorff

    
• • ·269-PA10 A primary school teacher with very infectious tuberculous laryngitis

    Page :35

    S.T. Keizer, M. Vis

    
• • ·273-PA10 Evaluation de la prise en charge des patients tuberculeux diagnostiqués dans un service de pneumologie

    Page :35-36

    S. Bourcier, F. Delepierre, C. Chouaid, J.J. Hosselet, I. Monnet, K. Atassi, B. Housset

    
• • ·297-PA10 INH chemoprophylaxis: an Italian experience on 500 pts

    Page :36

    L.R. Codecasa, G. Besozzi, A. Sarassi, D. Cinguino, P.V. Mantellini

    
• • ·301-PA10 Factors affecting Heaf grade results in tuberculosis exposed and non-exposed social club populations in Liverpool

    Page :36

    Q. Syed, M.A. Bellis, P.D.O. Davies, N. Beeching, S. Jamieson, A. Steel

    
• • ·326-PA10 Tuberculous meningitis in Latvia

    Page :36-37

    M. Bratkowski, O. Bobrikova

    
• • ·327-PA10 Lung tuberculosis in elderly

    Page :37

    T. Cvok, D. Pešut, V. Kačar-Kukrić, Z. Švabić-Dergenc, G. Radosavljević-Ašić

    
• • ·330-PA10 The influence of antituberculosis drugs on hepatic function in children

    Page :37

    Lj. Jakovski, L. Nikolova, T. Jakovska

    
• • ·329-PA10 Achievement rate of sputum negativization in cases with advanced tuberculosis among the refuges in Yugoslavia

    Page :37

    V. Kuruc, S. Pavlović, Dj. Radaković, A. Vukelić, N. Guša

    
• • ·338-PA10 Secondary inactive tuberculosis and bronchial reactivity

    Page :37-38

    M. Pavlović

    
• • ·340-PA10 Contribution du diagnostic invasive au modéle du traitement de la TB pulmonaire

    Page :38

    D. Subotić, V. Čemerikić, D. Mandarić, B. Bulajić

    
• • ·352-PA10 Laboratory acquired tuberculosis

    Page :38

    H. van Deutekom, P.G.H. Peerbooms, G.J.J. van Doornum, R.A. Coutinho

    
• • ·359-PA10 Immunosuppressive therapy and TB

    Page :38-39

    V. Ẑugić, V. Vuc̆inić, J. Videnović

    
• • ·360-PA10 Tuberculosis in pregnancy and postpartal period — our experience

    Page :39

    N. Bogdanović, G. Mrc̆ić-Martinović, V. Z̆ugić

    
• • ·361-PA10 The effectiveness of tuberculosis chemotherapy combined with immunomodulator

    Page :39

    L. Osipova, L. Kuznetsova, T. Gots, A. Kuznetsov

    
• • ·363-PA10 Tuberculosis in patients with diabetes mellitus

    Page :39

    V. Vuc̆inić, O. Durić, V. Z̆ugić, J. Videnović

    
• • ·374-PA10 Differential diagnosis of lung cancer and tuberculosis in lung and bronchus

    Page :39-40

    R.Y.U. Romanova, M.A. Goncharskaya, V.Ya. Gergert, G.V. Evguschenko

    
• • ·375-PA10 Pulmonary function in patients with hematogenous lung tuberculosis

    Page :40

    A. Vidoevska, M. Jonchevska, B. Ilievska

    
• • ·393-PA10 Unusual radiographic image of pulmonary TBC

    Page :40

    J. Videnović, O. Djurić, V. S̆kodrić

    
• • ·394-PA10 Extrapulmonary TBC — review of cases of specific laryngitis

    Page :40

    J. Videnović, O. Djurić, V. S̆kodrić

    
• • ·413-PA10 The treatment of tuberculous empyema

    Page :40-41

    Ş. Canan, Ç. Muharrem, H. Semih, K. Murat, U. Aziz, Ü. Senol, A. Bülent

    
• • ·448-PA10 Bronchoscopic picture in children with diagnosed pulmonary tuberculosis

    Page :41

    J. Zilkowski, R. Borkowska, M. Dobkowska, K. Ceglecka-Tomaszewska, J. Szubiński, B. Napieralska, M. Kulus

    
• • ·011-PA10 Epidemiological tuberculosis control in the Republic of Belarus

    Page :41

    V. Borschchevski, O. Kalechits, A. Bogomazova

    
• • ·022-PA10 Tuberculosis incidence in Scotland is increasing in the young and the elderly

    Page :41

    J.S. Duffield, W.H. Adams, M. Anderson, A.G. Leitch

    
• • ·026-PA10 Population-genetic approach in studying predisposition to lung tuberculosis

    Page :41-42

    D. Pesut, D. Marinkovic

    
• • ·078-PA10 Tuberculin screening at a hostel for homeless men

    Page :42

    S. Jamieson, C. Williams, P. Davies

    
• • ·092-PA10 Studies of the anthraco-silicosis with tuberculosis in 122 cases

    Page :42

    Lang Wenfang

    
• • ·109-PA10 Evolution des tuberculoses extrarespiratoires et son retentissement dans le programme national de contrôle de la tuberculose

    Page :42

    C. Didilescu, M. Jalbǎ, C. Marica

    
• • ·116-PA10 La tuberculose pulmonaire chez les vaccinés par le BCG

    Page :42-43

    M.L. Megdiche, A. Hamzaoui, A. Chabbou, B. Gharbi

    
• • ·117-PA10 The relationship of ethnic mix and social deprivation to the prevalence of tuberculosis

    Page :43

    M.J. Doherty, D.P.S. Spence, C.S.D. Williams, P.D.O. Davies

    
• • ·125-PA10 Tuberculose en milieu carcéral dans un pays en developpement. Madagascar de 1990 à 1993

    Page :43

    G. Auregan, F. Rakotomanana, P. Boisier

    
• • ·127-PA10 Tuberculosis after discontinuation of the BCG revaccination — follow-up at 5 years

    Page :43-44

    M. Tala-Heikkilä

    
• • ·139-PA10 La morbidité tuberculeuse de 1982 a 1994 en Algérie

    Page :44

    M. L'Hadj, R. Amrane, O. Fissah

    
• • ·152-PA10 Evolution of TBC in Chile

    Page :44

    M. Zúñiga, M. Rojas

    
• • ·180-PA10 Socio-economic conditions and their influence on tuberculosis incidence and outcome in Poland

    Page :44

    M. Miller, J. Masztalerz, I. Szczuka, Z. Piasecki

    
• • ·191-PA10 The uneven distribution of TB cases in a suburb with a high TB incidence

    Page :44-45

    R.P. Gie, N. Beyers, P.R. Donald, H.S. Schaaf, S. Van Zyl, L. Zietsman

    
• • ·193-PA10 National tuberculin survey of Kenya 1986–1990. Results and trend of the annual risk of tuberculous infection from 1959 till 1989

    Page :45

    O. Swai, D. Kwamanga, R. Agwanda, M. Bosman, G. Idukitta, O. Misljenovic

    
• • ·197-PA10 Estimated risk of tuberculosis in years after infection with Mycobacterium tuberculosis

    Page :45

    J.T.R. Wilcke, A. Kok-Jensen

    
• • ·210-PA10 Risk of first time pulmonary tuberculosis in Mycobacterium tuberculosis infected Danes in relation to age

    Page :45

    A. Kok-Jensen, T.R. Wilcke

    
• • ·238-PA10 Urban tuberculosis control in sub-Saharan Africa: the need for new approaches

    Page :45-46

    M. Bosman, D. Kibuga, R. Msiska

    
• • ·264-PA10 Occurrence of clusters of Mycobacterium tuberculosis infection in north-west London using RFLP typing

    Page :46

    D. Kumar, N. Saunders, J. Watson

    
• • ·268-PA10 Projet d'étude épidemiologique de la tuberculose dans l'Est Parisien

    Page :46-47

    F. Carrat, M. Febvre, V. Lalande, J.L. Mesnard, A.J. Valleron, J.L. Petit, J. Frottier, B. Lebeau

    
• • ·279-PA10 Use of molecular epidemiology (ME) to plan and evaluate tuberculosis (TB) control strategies

    Page :47

    P. Hopewell, P. Small, C. Daley, J. Hahn, A. Moss, G. Schecter

    
• • ·280-PA10 Estimating the risk of TB transmission in airliners and other confined public places

    Page :47

    E.A. Nardell

    
• • ·320-PA10 Estimation du Risque Annuel d'Infection tuberculeuse en zone rurale, Adzope, Côte d'Ivoire. Enquête en milieu scolaire en 1995

    Page :47-48

    C. Doulhourou, G. Nekouressi, P. Msellati, M. Saki, K. Toure, M. Peyre, I.M. Coulibaly

    
• • ·332-PA10 Recent trends of tuberculosis in Slovakia

    Page :48

    S̆. Urban, A. Bajan, J. Trenkler

    
• • ·333-PA10 The trend of TB meningitis in the last 24 years in Greece

    Page :48

    P. Spyridis, F. Karachaliou, J. Polychroni, N. Karli, C. Siafas, Ch. Bartsokas, C. Sinaniotis

    
• • ·347-PA10 Design & analysis issues for annual risk of infection surveys

    Page :48

    P.J. Smith, N. Binkin, K.G. Castro

    
• • ·355-PA10 A comparison of the incidence of TB between the Republic of Ireland and Northern Ireland

    Page :48-49

    P. Kelly, D. McKeown, G. Varghese, L. Clancy

    
• • ·395-PA10 Notification of tuberculosis in Hong Kong: which patients are notified twice?

    Page :49

    R.M. Hardie, C.M. Tam, M. Ng

    
• • ·418-PA10 1985–1994 Routine tuberculin testing among students in Italy

    Page :49

    G. Salamina, A. Infuso

    
• • ·435-PA10 Le RAI à Phnom Penh et au Cambodge en 1995

    Page :50

    K. Phuong, P-Y. Norval, T. Bakhim, K.K. San, N. Sovann

    
• • ·439-PA10 La situation épidémiologique de la tuberculose au Tchad

    Page :50

    J.P. Baptiste, E. Morin, P.-Y. Norval, Nana De Mane

    
• • ·472-PA10 Molecular epidemiology of TB in South African gold mines

    Page :50-51

    P. Godfrey-Faussett, J. Murray, S. Shearer, M. Bruce, P. Sonnenberg, B. Kambashi, C. Mee

    
• • ·471-PA10 Genetic diversity among M. tuberculosis in Zambia

    Page :51

    M. Bruce, B. Kambashi, P. de Haas, G. Kahenya, P. Godfrey-Faussett

    
• • ·442-PA10 Tuberculosis morbidity in Lithuania

    Page :51

    D. Gaidamoniene, P. Butkiene, J. Daniene, D. Slapkauskaite

    
• • ·454-PA10 Tuberculin conversion among health care workers in a general hospital of Rio de Janeiro, Brasil. Preliminary results

    Page :51-52

    N. Boéchat, G. Muzzy de Souza, R. Cravo, F. Mellow, A. Viana, Z. Nunes, O. Oliveira, A. Kritski

    
• • ·046-PA10 Peculiarities of clinical symptoms, character of immune changes in children suffering from tuberculosis with clinical signs of acquired immunodeficiency syndrome

    Page :52

    V.P. Kostromina, E.V. Derkach, V.A. Rushchak

    
• • ·054-PA10 Radiographic pulmonary changes in children with tuberculosis

    Page :52

    I. Koncul, D. Milković, M. Raos

    
• • ·103-PA10 Tuberculosis and mycobacteriosis in children in the Czech Republic

    Page :52

    K. Kr̆epela

    
• • ·066-PA10 A retrospective analysis in cases with primary pulmonary tuberculosis

    Page :52

    N.N. Ekim, E. Levent, C. Küsmez

    
• • ·162-PA10 Immigration and tuberculosis (TB) in young children, San Diego County, CA

    Page :52-53

    T.A. Kenyon, C. Driver, E. Schneider, M. Daley, S.E. Valway, E. Haas, K. Moser, I.M. Onorato

    
• • ·190-PA10 The outcome of children treated for endobronchial tuberculosis

    Page :53

    R.P. Gie, N. Beyers, H.S. Schaaf, P.R. Donald, J. Te Water Naudé, D.R. Perkins

    
• • ·334-PA10 Mantoux skin test as a routine screening performed on pediatric patients during hospitalization

    Page :53

    P. Spyridis, A. Gelesme, G. Zlatanos, M. Tsanaktski, J. Mathioudakis, N. Myriokefalitakis, C. Sinaniotis

    
• • ·296-PA10 The value of using score charts in diagnosing childhood tuberculosis

    Page :53

    E. Dağh, A. Pamukçu, G. Dolunay, F. Daras, E. Pekdemir, Ş. Kodal, D. Kocaoğlu, T. Koralhoca, N. Bekiroğlu

    
• • ·335-PA10 Cytogenetic effects of isoniazid (INH) monotherapy and/or Mycobacterium tuberculosis infection (TBC-I) in children

    Page :54

    P. Spyridis, S. Kitsiou, A. Galla, A. Tsezou, D. Gourgiotis, C. Siakavellas, E. Kavazarakis, C. Sinaniotis

    
• • ·339-PA10 Lung tuberculosis in children of Croatia in relation to clinical experience, war circumstances and epidemiologic data

    Page :54

    M. Medar-Lasic, L. Zimic, I. Zoricic-Letoja

    
• • ·444-PA10 Enzymes in serum of children, fast and slow isoniazid acetylators

    Page :54

    S. Dodig, M. Medar-Lasić, L. Zimić, J. Z̆ivc̆ić, I. C̆epelak

    
• • ·351-PA10 Tuberculous lymphadenitis in children

    Page :54

    L. Zimic, M. Medar-Lasic, I. Zoricic-Letoja

    
• • ·128-PA10 Occupational lung disease among black TB patients — a rural South African experience

    Page :54-55

    F.B. Hibbeler

    
• • ·308-PA10 Est-il bénéfique d'introduire le dosage de l'angiotensine convertase parmi les tests pour les maladies professionelles respiratoires?

    Page :55

    E. Păunescu, A. Şerbescu, L.M. Păunescu

    
• • ·311-PA10 The report of epidemic survey and preventive with curative procedures of chronic bronchitis and asthma to 120000 textile workers in Shandong province, China

    Page :55

    Wang Yingnian, Han Zongmei

    
• • ·317-PA10 Level and severity of airway obstruction in farmers

    Page :55-56

    F. Bonnaud, A. Vergnenègre, B. Melloni, X. d'Arco, M.T. Antonini

    
• • ·349-PA10 Effect of recurring pneumonia on ventilatory lung function in schoolchildren and young people

    Page :56

    I. Zoric̆ić-Letoja, F. Pavic̆ić, M. Lasić

    
• • ·370-PA10 A 12-year follow-up of respiratory disease in farmers

    Page :56

    A. Rask-Andersen, Å. Lundin

    
• • ·451-PA10 Risk factors of chronic respiratory disorders in a sample of farmers of middle Italy

    Page :56

    D. Talini, A. Monteverdi, A. Benvenuti, G. Innocenti, F. Di Pede, M. Lemmi, G. Campinoti, G. Viegi, P.L Paggiaro

    
• • ·001-PA11 Specific features of bronchial asthma during pregnancy, treatment and health status of newborns

    Page :56-57

    S.N. Vakhrameeva

    
• • ·002-PA11 Steroid-resistance in asthma patients and the application of the nicotinamide

    Page :57

    L. Kogosova, N. Kovalenko, V. Lubenko, F. Novosad, A. Markov

    
• • ·003-PA11 Influence du Salmeterol sur l'asthme à l'aspirine et l'odorat

    Page :57

    F. Mihaltan, Ph. Muir, H.F. Muir

    
• • ·004-PA11 A comparison of different bronchodilators in tuberculosis patients

    Page :57

    A.A. Wiesel, M.F. Yaushev, E.A. Sabitov

    
• • ·008-PA11 Correction possibilities of pulmonary hypertension in chronic obstructive pulmonary diseases

    Page :57-58

    A. Visokinskas

    
• • ·009-PA11 Combinations of asthma and other allergic manifestations

    Page :58

    I. Cygaite, B. Vasiliauskas

    
• • ·014-PA11 Influence of environment factors and mode of life bronchial asthma in early age children

    Page :58

    V.A. Revyakina, L.S. Namazova, N.I. Voznessenskaya

    
• • ·015-PA11 New aspects of preventive therapy program to asthmatic children

    Page :58

    L.S. Namazova, I.I. Balabolkin, V.A. Revyakina

    
• • ·016-PA11 Estimation of the role of the thymus in bronchial asthma patients

    Page :58-59

    V.T. Volkov

    
• • ·017-PA11 Estimation of pathogenetic part of oxalemia under bronchial asthma

    Page :59

    V.T. Volkov

    
• • ·027-PA11 The estimation of taurine, clycine and B₆ influence to bronchial asthma

    Page :59

    V.T. Volkov

    
• • ·033-PA11 Is night bronchial asthma a heliocosmic phenomenon?

    Page :59-60

    V.T. Volkov

    
• • ·039-PA11 Mortality rates from asthma and COPD in Warsaw

    Page :60

    K. May, Z. Piasecki, S. Wesolowski

    
• • ·040-PA11 The clinical effect of low molecular fraction of thymus in asthma patients

    Page :60

    L.V. Kuznetsova, T.Yu. Gots

    
• • ·047-PA11 Autoimmune reactions in children with bronchial asthma

    Page :60

    O. Lasytsya, H. Oussova

    
• • ·057-PA11 Chronic cor-pulmonale in Ethiopian patients: underlying causes with emphasis on bronchial asthma

    Page :60-61

    G. Aderaye

    
• • ·068-PA11 Paradoxical reactions to environmental ozone?

    Page :61

    G. Praml, P. Höppe, J. Lindner, G. Rabe, G. Fruhmann

    
• • ·074-PA11 L'environement et l'asthme chez l'enfant

    Page :61

    B. Tayeb

    
• • ·088-PA11 Preliminary results of multicenter study about bronchial asthmatics in Istanbul

    Page :61-62

    B. Gemicioğlu, F. Erkan, M. Ereğlen, E. Akkaya, G. Çamsari, B. Tutluoğlu, M. Akman, E. Öztürk

    
• • ·096-PA11 Acupuncture pendant un traitement complexe des malades à asthme bronchique hormonodepéndante

    Page :62

    V. Lacusta, A. Moscovciuc, V. Baraniuc, L. Procopisin, I. Cosciug, L. Stefănaru, I. Sincarenco

    
• • ·100-PA11 L'information médicale et la publicité sur les médicaments de l'asthme dans les pays du Maghreb

    Page :62

    M. Ouamri, N. Sidi-Mansour, S.E. Meddour

    
• • ·098-PA11 Prévalence de l'asthme bronchique

    Page :62

    A. Moumeni, R. Amrane, D. Vervloet, D. Charpin, J. Charpin, H. Aidaoui

    
• • ·101-PA11 Asthme et chirurgie

    Page :62

    M. Ouamri, B. Haddadi

    
• • ·105-PA11 The importance of reversibility in the assessment of different bronchial obstruction in asthma and chronic bronchitis

    Page :62-63

    E. Öztürk, Y. Yilmazkaya, A. Hazar, S. Kuleci, M. Kurutepe

    
• • ·120-PA11 The investigation of free-radical changes during the inflammatory and allergic diseases

    Page :63

    L.V. Kuznetsova, T.Yu. Gots, V.I. Litus

    
• • ·136-PA11 Frequency of bronchial asthma and distribution of its types

    Page :63

    V. Kosjerina Oštrić

    
• • ·142-PA11 Neuro-urological evaluation of patients with asthma who have been using β₂ agonists for a long time (Preliminary Study)

    Page :63

    Z. Kartaloğlu, R. Aydilek, M. Saraçoğlu, S. Albayrak, A. Ilvan, K. Cerrahoğlu

    
• • ·145-PA11 Serum electrolytes in bronchoalveolar lavage fluid in patients with bronchial asthma

    Page :63-64

    Z. Kartaloğlu, R. Aydilek, A. Ilvan, K. Cerrahoğlu, E. Kunter, O. Okutan

    
• • ·158-PA11 Comparative effectiveness of Atrovent and Berotec therapy in patients whith bronchial asthma

    Page :64

    U.I. Feschenko, L.A. Yashina, M. Poluanskaya

    
• • ·176-PA11 Sputum eosinophilia in asthma

    Page :64

    A. Spanevello, G.B. Migliori, A. Satta, C.V. Landoni, M. Neri

    
• • ·195-PA11 A clinical trial of nebulised magsulf vs nebulised salbutamol in acute severe bronchial asthma

    Page :64

    H.S. Mangat, G.A. D'Souza, M.S. Jacob, A. Mercy

    
• • ·262-PA11 Acid-base disturbances in acute asthma severity classification

    Page :64-65

    S. Radovanovic, V. Petrovic, B. Milenkovic, A. Ilic, M. Vukcevic

    
• • ·302-PA11 Asthma deaths in OAUTHC, Ile-Ife

    Page :65

    G.E. Erhabor, A.O. Adigun

    
• • ·303-PA11 Trigger factors for asthma in Nigerian asthmatics

    Page :65

    G. Erhabor

    
• • ·316-PA11 A spectral analysis of the heart rate in bronchial asthma patients

    Page :65

    V.I. Trophimov, V.N. Martchenko

    
• • ·342-PA11 Two years of asthma club activities for asthma patients

    Page :65-66

    L. Raudla, E. Mesimaa

    
• • ·356-PA11 Occurrence and management of asthma and chronic bronchitis in Estonia

    Page :66

    H.-M. Loit, L. Jannus-Pruljan, E. Lillak, E. Raukas, K.-M. Tomberg, R. Valjaots, M. Kala, A. Nagelmann, J. Pôlluste

    
• • ·372-PA11 Chlamydia pneumoniae infection in bronchial asthma

    Page :66

    E. Fernández, A. Orts, M.J. Martin, F. Cañizares, C. Morales, F.G. Vargas, A. Espejo, J.M. Navarro, J. Mendoza

    
• • ·385-PA11 High altitude climatotherapy in bronchial asthma patient management

    Page :66

    N. Brimkulov, M.M. Mirrakhimov

    
• • ·387-PA11 Asthma symptom frequency predicts airway hyperresponsiveness

    Page :66-67

    H.K. Reddel, C.M. Salome, A.J. Woolcock

    
• • ·392-PA11 Self care manual for bronchial asthma

    Page :67

    D. Behera, B. Kaur, S. Sharma, D. Gupta

    
• • ·396-PA11 La prise en charge des asthmatiques. Evaluation d'une intervention de santé au niveau d'un secteur sanitaire d'Algérie

    Page :67

    S. Mahi-Taright, M. Belhocine, N. Ait-Khaled

    
• • ·399-PA11 Serum interleukin-6 levels in patients with asthma

    Page :67

    A. Kocabaş, S. Hastürk, R. Güneşacar, E. Erken, M. Yaşar, T. Göçmen, R. Burgut, M. Avşar

    
• • ·401-PA11 The value of Phadiatop and total serum IgE for respiratory allergy

    Page :67-68

    A. Kocabaş, M. Yaşar, Ş. Idrisoğlu, E. Erken, S. Hastürk, R. Burgut

    
• • ·428-PA11 ISAAC, Klang Valley, Malaysia

    Page :68

    J.A. de Bruyne

    
• • ·437-PA11 Correlation between bronchial hyperreactivity (BH), atopy, bronchoalveolar lavage (BAL), and their influence on the development of chronic obstructive pulmonary disease (COPD)

    Page :68

    R. Bilancia, D. Margiotta, G. Cantacessi, E. Spampani, P. Roselli, A. Posca, A. Quaranta

    
• • ·445-PA11 Persistent wheezing as an indication for bronchoscopy

    Page :68

    Z. Ẑivković

    
• • ·475-PA11 Risk factors for asthma in Kenya school children

    Page :68-69

    J. Odhiambo, L. Ng'ang'a, M. Mungai, C. Gicheha, J. Nyamwaya, G. Mwawasi, M.R. Becklake, R. Menzies, P.T. Macklem

    
• • ·025-PA11 Passive smoking as a determinant of bronchial hyperreactivity in children with respiratory diseases

    Page :69

    N.F. Dorokhova, V.K. Tatochenko, V.S. Reutova, S.G. Shmakova

    
• • ·045-PA11 Infradian oscillations of vegetative nervous system functional state and immune status in children with frequent acute respiratory viral infection

    Page :69

    A.V. Kochkin, A.V. Hasanova

    
• • ·141-PA11 ARI in Tanzanian children

    Page :69

    S.M Egwaga

    
• • ·321-PA11 Community acquired pneumonia in adults: clinical features and outcome in Africa and Europe

    Page :69-70

    O. Sow, A. Diallo, S. Soumah, M.K. Conde, M. Frechet, P. Diot, E. Boissinot, E. Lemarie

    
• • ·343-PA11 Mycoplasma infection — initially suggestive specific infection

    Page :70

    V. Kačar

    
• • ·344-PA11 Q fever — pseudotumor without fever

    Page :70

    V. Kačar

    
• • ·415-PA11 Antimicrobial resistance surveillance among bacteria isolated from child with pneumonia in Egypt

    Page :70

    N. Kahlalf

    
• • ·099-PA11 Les complications respiratoires des corps étrangers laryngo-tracheo-bronchiques chez l'enfant

    Page :70-71

    N. Ouamri, K. Benmouhoub

    
• • ·135-PA11 Cystic fibrosis

    Page :71

    V. Kosjerina-Oštrić, Z. Kosjerina, B. Djurić, Z. Pavlović-Popović, Dj. Paličko

    
• • ·246-PA11 The factors of bad prognosis in neonatal pneumonia complicated by acute respiratory insufficiency

    Page :71

    J. Kasprzyk, U. Godula-Stuglik, G. Kasprzyk, K. Ziora

    
• • ·358-PA11 Candida albicans in bronchial aspirates in newborns requiring prolonged intubation due to pneumonia

    Page :71

    J. Bursa, U. Godula-Stuglik, J. Gajewska

    
• • ·376-PA11 Etiologic aspects of pneumonia with atelectasis in children under age of three years

    Page :71-72

    M. Dilberovska, S. Petrovska, B. Aleksievski, L. Jakovski

    
• • ·389-PA11 Non-sporeforming anaerobic bacteria in lower respiratory infections

    Page :72

    E. Jassem, A. Kȩdzia, L. Wolska, A. Siemińska, K. Szeleżyński

    
• • ·446-PA11 Severe childhood pneumonia in intensive care unit

    Page :72

    Z. Ẑivković

    
• • ·035-PA11 The necessity of reconsidering the definition of chronic obstructive bronchitis

    Page :72

    V.T. Volkov

    
• • ·131-PA11 Sarcoidosis of the myocard

    Page :72-73

    Z. Pavlović-Popović, B. Djurić

    
• • ·155-PA11 Studies on Histoplasma capsulatum infection and diagnostic methods for histoplasmosis in patients with lung TB

    Page :73

    E. Wu, M.D. Sheng

    
• • ·232-PA11 Eosinophil pneumonia

    Page :73

    V. Kosjerina-Oštrić

    
• • ·253-PA11 Spirométrie à distance

    Page :73

    V. Sokolova, V. Streltsov, L. Bronskaia

    
• • ·290-PA11 Environmental mycobacterial lung disease: clinical course, concurrent factors and treatment with conventional drugs and interferon-γ

    Page :73-74

    L. Olsson, J. Olofson, L.O. Larsson

    
• • ·364-PA11 Atypical mycobacteria — clinical course, diagnostic, treatment

    Page :74

    J. Videnović, O. Durić, V. Ẑugić, V. Vućinic

    
• • ·384-PA11 Selective mediastinoscopy in the preoperative study of bronchogenic carcinoma

    Page :74

    L. López, F. Rodríguez de Castro, P. Facal, S. Quevedo, F. Cruz, M. Hussein, J. Freixinet

    
• • ·390-PA11 Treatment of pulmonary aspergilloma with itraconazole

    Page :74

    M. Wierzbicka, B. Podsiato, S. Wesotowski, I. Bestry

    
• • ·411-PA11 Pulmonary mucormycosis

    Page :74-75

    Ş. Canan, K. Murat, Ç. Muharrem, H. Semih, A. Bülent

    
• • ·412-PA11 Pulmonary aspergilloma

    Page :75

    Ş. Canan, Ç. Muharrem, U. Aziz, H. Semih, K. Murat, Ç. Benan, Ö. Ibrahim

    
• • ·429-PA11 Study of aerobic microbial flora of upper respiratory tract of chemical war wounded

    Page :75

    H. Heidarnajad, A. Ahmadyan

    
• • ·430-PA11 Diagnostic value of fiberoptic bronchoscopy in the diagnosis of pulmonary hydatid cyst

    Page :75

    H. Heidarnajad, S.S. Azar

    
• • ·443-PA11 Subpopulations of T lymphocytes in patients with disseminated lung disease

    Page :76

    J. Daniene, D. Gaidamoniene, M. Liubartaite, M. Tamosiunas

    
• • ·473-PA11 Primo-infection pulmonaire due à Mycobacterium avium intracellulare chez l'enfant

    Page :76

    H. Levrey, G. Bellon

    
• • ·452-PA11 Le traitement médical de la douleur du cancer bronchique en milieu spécialisé

    Page :76

    S. Nafti

    
• • ·174-PC11 The Uganda National Tuberculosis/Leprosy programme

    Page :76-77

    S. Pomiato, G. Gargioni, F. Adatu

    
• • ·213-PC11 A cohort evaluation of tuberculosis treatment results in Mexico

    Page :77

    A. Garcia-Cruz, R. Olvera Castillo, C. espinosa

    
• • ·225-PC11 Shortcourse chemotherapy implementation in Embu district

    Page :77

    J. Kangangi, D. Kibuga

    
• • ·236-PC11 Outcome of tuberculosis treatment: a comparison of Alberta, Canada and Nicaragua

    Page :77-78

    N. Kassam, R. Cruz, A. Fanning

    
• • ·267-PC11 Measuring outcome of smear positive tuberculosis

    Page :78

    J.R. Glynn, P.E.M. Fine, D.K. Warndorff, J.M. Pönnighaus

    
• • ·371-PC11 Outcome of tuberculosis treatment in Queensland (Qld), Australia 1985–1992

    Page :78-79

    A. Konstantinos, A.M. Patel, P. Derhy, B. George

    
• • ·378-PC11 A comparison of the tuberculosis control programs in San Francisco, USA and Zürich, Switzerland

    Page :79

    H. Shang, N. Rose, O. Brändli, G. Schecter

    
• • ·400-PC11 Fate of smear positive pulmonary tuberculosis patients in Turkey

    Page :79

    A. Kocabaş, R. Burgut, E. Kibaroğlu, G. Seydaoğlu, N. Bozdemir

    
• • ·249-PC11 Outcome of patients treated for pulmonary TB in Vaud county

    Page :79-80

    P. Coulon, J.P. Zellweger

    
• • ·434-PC11 Cohorts of treatment of positive smear pulmonary tuberculosis with short course 2RHZE/4R₂H₂ scheme in operational conditions in Peru

    Page :80

    P.G. Suarez, O.C. Jave, I.T. Sabogal, C.A. Bonilla, J. Portocarrero, R. Canales, E. Alarcon, D. Velasquez, D. Victoria

    
• • ·463-PC11 Cohort evaluation of treatment results, Paris

    Page :80

    A.G. Cruz, Z. Gulbaran, D.A. Enarson

    
• • ·464-PC11 Cohort evaluation of treatment results, British Columbia

    Page :80-81

    J.M. Fitzgerald, A. Garcia-Cruz, R.K. Elwood, D.A. Enarson

    
• • ·465-PC11 Cohort evaluation of treatment results, Beijing

    Page :81

    Li-Xing Zhang

    
• • ·319-PA11 Aspects socio-anthropologiques de l'abandon de traitement par des malades sous traitement antituberculeux dans les CAT d'Abidjan

    Page :81

    A.D. Blibolo, P. Msellati, I.M. Coulibaly, C. Doulhourou, L. Vidal

    
• • ·369-PA11 Treatment of pulmonary tuberculosis in the tertiary care setting

    Page :81-82

    W.L. Wobeser, L. Yuan

    
• • ·403-PA11 Comparision of treatment outcome of patients with pulmonary tuberculosis managed by general practitioners and chest physicians

    Page :82

    A. Kocabaş, R. Burgut, G. Seydaoğlu, E. Kibaroğlu, N. Bozdemir

    
• • ·424-PA11 Compliance among tuberculosis patients with short course chemotherapy in the national tuberculosis centre, Thimi, Bhaktapur, Nepal

    Page :82

    T.M. Shakya, K.B. Shrestha

    
• • ·426-PA11 A cohort evaluation of tuberculosis treatment results in Argentina

    Page :82-83

    G.H. Poggio

    
• • ·436-PA11 Treatment efficiency of pulmonary tuberculosis in rural patients

    Page :83

    A.S. Tolstikh

    
• • ·474-PA11 Defaulting in smear-positive tuberculosis patients in urban area of Cairo, Egypt

    Page :83

    E.J.M. De Coster, F.M. Tolba, S. El Ibiary

    
• • ·055-PA11 Increased production of interleukin-10 by human blood mononuclear cells stimulated with multidrug-resistant Mycobacterium tuberculosis (MDRTB)

    Page :83

    H. Fujiwara, T. Aotani, I. Tsuyuguchi

    
• • ·069-PA11 Caractérisation de la cible moléculaire de l'isoniazide chez M. tuberculosis

    Page :83-84

    A. Quémard, A. Dessen, J.C. Sacchettini, W.R. Jacobs, J.S. Blanchard

    
• • ·095-PA11 DNA fingerprinting of a multidrug resistant tuberculosis outbreak in Buenos Aires

    Page :84

    N. Morcillo, A. Alito, M.I. Romano, A. Cataldi, A. Dolmann, A. Reniero, I.N. de Kantor

    
• • ·124-PA11 Rapid drug susceptibility testing of Mycobacterium tuberculosis by a microdilution broth minimum inhibitory concentration (MIC) method

    Page :84

    M.D. Yates, M.A.S. Telles

    
• • ·348-PA11 Rapid direct in vitro susceptibility testing of Mycobacterium tuberculosis using microbroth culture and DNA quantification

    Page :84-85

    A. Roth, M. Kaffarnik, D. Neugebauer, H. Mauch

    
• • ·377-PA11 In vitro activity of ciprofloxacin against Mycobacterium tuberculosis

    Page :85

    M. Jonchevska, S. Talevski, E. Bakalova, O. Kungulovska

    
• • ·006-PA11 Chemotherapy of patients with lung tuberculosis and with drug resistant mycobacteria

    Page :85

    V.M. Petrenko, J.B. Bialik, S.A. Cheren'ko

    
• • ·063-PA11 Clinical study on the drug resistance in the initial treatment of pulmonary tuberculosis

    Page :85-86

    S.D. Song, M.H. Sohn, S.K. Park

    
• • ·073-PA11 Early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis compared to that of isoniazid

    Page :86

    F.J.H. Botha, F.A. Sirgel, B.W. van de Wal, D.P. Parkin, P.R. Donald, R. Schall, D.A. Mitchison

    
• • ·140-PA11 Causes of ineffective treatment in patients with pulmonary tuberculosis

    Page :86

    V. Petrenko, S. Cherenko, I. Byalik, B. Vengerov

    
• • ·091-PA11 Use of sparfloxacin for the treatment of multi-drug resistant pulmonary tuberculosis

    Page :86

    T. Schaberg, C. Specht, H. Stephan, H. Lode

    
• • ·150-PA11 Reasons for chronic culture positive pulmonary tuberculosis

    Page :87

    D. Michalowska-Mitczuk, J. Kuś, M. Miller, Z. Zwolska-Kwick

    
• • ·151-PA11 The treatment of the patients with sputum culture positive chronic pulmonary tuberculosis

    Page :87

    D. Michalowska-Mitczuk, J. Kuś, M. Korzeniewska-Koseta, Z. Zwolska-Kwiek, M. Miller

    
• • ·189-PA11 Lung resection in unrecognized tuberculosis

    Page :87

    A. Pokorný

    
• • ·094-PA11 In vitro activity of antimicrobial agents alone and in combination against Mycobacterium tuberculosis (TB) and M. avium complex (MAC) isolated in Argentina

    Page :87-88

    N. Morcillo, G. Poggio, J. Elbaba, I.N. de Kantor

    
• • ·205-PA11 Tuberculosis clinic for high-risk non-adherent patients. Results

    Page :88

    J. Alcaide, M.N. Altet, J. Pascual, M. Del Val, F. Lopez, J. Solsona, I. Parrón, C. Albiñana, M. Fontanals, Ll. Salleras

    
• • ·254-PA11 Drug resistance of mycobacteria isolated from patients: a report from Iran

    Page :88

    A. Bahrmand, H. Madani, V. Bakaev

    
• • ·307-PA11 Bacteriological status of outpatients, after relapse, with pulmonary tuberculosis treated with 2RHZ 4RH

    Page :88

    S. Natal, A. Barreto, R. Lopes, L. Lopes, C. Campos, G. Gerhardt

    
• • ·323-PA11 Comparison of ofloxacin and norfloxacin for treating multidrug resistant pulmonary tuberculosis

    Page :89

    F. Fiuza de Melo, J.B. Affiune, J. Ide Neto, M. Seiscento, A. Castelo

    
• • ·324-PA11 Treatment of multidrug-resistant pulmonary tuberculosis (MDR-TB) with scheme chemotherapy including ofloxacin, clofazimine and amikacin

    Page :89

    M. Seiscento, F.A.F. Melo, J. Ide Neto, J.B. Affiune, A. Noronha

    
• • ·337-PA11 A propos de 36 cas de tuberculoses pulmonaires soumis à un schéma de retraitement

    Page :89

    Pr Berrabah

    
• • ·345-PA11 Immunogenetic constellations involved in different courses of tuberculous infection

    Page :89-90

    P. Santos, A. Martinho, O. Simões, M. Brenden, G. Plum, A. Figueiredo, G. Mauff, H. Breda-Coimbra, A. Segorbe-Luís

    
• • ·410-PA11 Usage of the pyrimidine derivates at ineffective treatment of pulmonary tuberculosis

    Page :90

    A.P. Tsybulkin, A.A. Viesel, Yu.D. Slabnov, O.V. Firsov

    
• • ·417-PA11 Use of 3(4.5 dimethyl-2 thiazoly) 2.5 dipheny 1-2H-tetrazolium bromide (MTT) for detection of drug resistant Mycobacterium tuberculosis

    Page :90

    R. Mshana, H. Miörner, G. Tadesse, G. Abate

    
• • ·467-PA11 Le traitement de la tuberculose pulmonaire à bacilles multi-resistants, à Alger

    Page :90-91

    M. Bellamdani, M. Hamadache

    
• • ·070-PA11 Drug resistance: Blackburn UK 1980–1994

    Page :91

    L.P. Ormerod

    
• • ·115-PA11 Résistance de M. tuberculosis aux antibiotiques

    Page :91

    Tuan Le Anh

    
• • ·076-PA11 The problem of drug resistance in Tibetan refugees

    Page :91

    D.F. Wares, P.D.O. Davies

    
• • ·146-PA11 Primary and secondary drug resistance of soldiers with pulmonary tuberculosis

    Page :91-92

    K. Cerrahoğlu, R. Aydllek, H. Öztürkeri, A. İlvan, Z. Kartaloğlu, O. Okutan

    
• • ·157-PA11 Drug resistance of Mycobacterium tuberculosis in patients in Zagreb, Croatia

    Page :92

    M. Kristić-Burić, A. Roz̆man

    
• • ·284-PA11 Study of resistance of M. tuberculosis in a reference center in Spain

    Page :92

    P. Ruiz, J. Guitiérrez, M. Casal

    
• • ·270-PA11 Drug resistance in tuberculosis patients in Poland — the magnitude of the problem

    Page :92

    I. Szczuka

    
• • ·223-PA11 Spread of multidrug resistant tuberculosis

    Page :92

    D.K. Kibuga

    
• • ·291-PA11 Multi-drug resistant tuberculosis in France (1992–1994)

    Page :92-93

    V. Schwoebel, B. Decludt, S. Haeghebaert, G. Torrea, V. Vincent, J. Grosset

    
• • ·292-PA11 Mycobacterial species identification and pattern of anti-TB drug resistance in three important pulmonary centers

    Page :93

    M. Foruzesch, P. Adibfar, L. Khalilzadeh, A. Sanami

    
• • ·298-PA11 Drug resistant TB in Italian and immigrant pts

    Page :93

    G. Besozzi, A. Sarassi, L.R. Codecasa, P.V. Mantellini, S. Lombardi

    
• • ·305-PA11 Initial drug resistance among pulmonary cases of tuberculosis in 1994 in Rio de Janeiro city

    Page :93-94

    A. Toledo, A. Barreto, G. Vasconcellos, C. Campos, G. Gerhardt, S. Natal, H. Oliveira, S. Dias, S. Aquino, S. Espirito Santo

    
• • ·397-PA11 Drug susceptibility of Mycobacterium tuberculosis isolated from HIV infected and no infected patients in Rio de Janeiro (Brazil)

    Page :94

    F.C.O. Fandinho, A.L. Kritski, H. Conde, L.S. Fonseca

    
• • ·422-PA11 Characteristics of patients with drug resistant and drug sensitive tuberculosis in Latvia in 1993 and 1994

    Page :94

    A. Kārklina

    
• • ·425-PA11 Community-based surveillance for drug resistance of Mycobacterium tuberculosis

    Page :94-95

    T. Tan-Torres, M. Mendoza

    
• • ·438-PA11 Multidrug resistant tuberculosis in the province of Florence (Italy)

    Page :95

    S. Nutini, E. Tortoli

    
• • ·453-PA11 Etude de la résistance de M. tuberculosis aux anti-tuberculeux à Madagascar

    Page :95

    S. Chanteau, O. Ratsirahonana, V. Rasolofo, C. Nirinainy, P. Boisier, F. Rakotomanana, M. Ratsitoharana, B. Bichat, G. Aurégan

    
• • ·455-PA11 Drug resistance to Mycobacterium tuberculosis during a four year period

    Page :95-96

    S. Nolchev, M. Trajchevska, S. Janachkova, M. Jonchevska, S. Koneska, S. Poniavich

    
• • ·005-PC11/12 Primary resistance to antituberculosis drugs in Galicia (N. W. Spain)

    Page :96

    D. Alvarez, L. Valdés, J.M. Valle, M.V. Martino

    
• • ·093-PC11/12 Enquiry into the extent of initial and acquired drug resistance to anti-tuberculosis drugs in Delhi, India

    Page :96

    N.K. Jain, D.R. Nagpaul, S.U. Bhakta, J.K. Aggarwal, S.K. Biswas, S.P. Khanna, U.C. Dhawan, R.K. Joshi, R.K. Mehra, S.K. Arora, D.K. Garg, D. Lal, C. Mohini, V.K. Dhingra, H. Raj, A. Laszlo

    
• • ·114-PC11/12 Pilot study for surveillance of drug resistant Mycobacterium tuberculosis in France

    Page :96-97

    B. Decludt, V. Schwoebel, S. Haeghebaert, J. Grosset

    
• • ·165-PC11/12 Drug resistant tuberculosis in New York City, 1991–1994

    Page :97

    P.I. Fujiwara, J.T. Crawford, C.L. Woodley, T.R. Frieden

    
• • ·187-PC11/12 Drug resistant tuberculosis in Korea

    Page :97

    S.J. Kim, G.H. Bai, Y.P. Hong, I.S. Kim

    
• • ·188-PC11/12 Surveillance of antituberculous drug resistance in Argentina

    Page :97-98

    
• • ·199-PC11/12 Résistance initiale aux antituberculeux à Yaoundé, Cameroun. Resultats préliminaires

    Page :98

    R. Bercion, C. Kuaban

    
• • ·208-PC11/12 Drug resistance of M. tuberculosis-complex isolates in Sierra Leone, West Africa

    Page :98

    G. Bretzel, F. Boillot, V. Sticht-Groh

    
• • ·220-PC11/12 The effect of directly observed therapy on resistant tuberculosis

    Page :98-99

    S.E. Weis, B. Nguyen, C. Edwards, K. Matty, B.H Foresman

    
• • ·265-PC11/12 The UK Mycobacterium Resistance Network 1994

    Page :99

    D. Bennett, J. Watson, M. Yates, T. Jenkins, S. McGuirk

    
• • ·325-PC11/12 Résistance de M. tuberculosis à Dakar en 1994

    Page :99

    A. Samb, M.F. Cisse, C.M.H. Seck, A.I. Sow, A.A. Hane

    
• • ·306-PC11/12 Global and acquired drug resistance in patients with pulmonary tuberculosis diagnosed during 1994 in Rio de Janeiro city

    Page :99

    A. Barreto, A. Toledo, G. Vasconcellos, C. Campos, G. Gerhardt, S. Natal, H. Oliveira, S. Dias, S. Aquino, S. Espirito Santo

    
• • ·331-PC11/12 Incidence in tuberculosis and antimicrobial resistance of Mycobacterium tuberculosis in Estonia in 1992–1994

    Page :100

    M. Danilovitch, H. Sillastu, A. Krüüner, E. Türi

    
• • ·350-PC11/12 Drug resistant tuberculosis in Lithuania

    Page :100

    K. Miskinis, B. Purvaneckiene

    
• • ·012-PA12 How to prevent smoking in Russia?

    Page :100

    A.N. Zubritsky

    
• • ·404-PC11/12 Resistant tuberculosis in Norway 1976–1994

    Page :100

    E. Heldal

    
• • ·048-PA12 Developing youth as advocates for tobacco use prevention: the smoke-free class of 2000

    Page :101

    S. Jaycox

    
• • ·049-PA12 Diffusion of a successful research model: ALA's African-American church based smoking cessation project

    Page :101

    S. Jaycox

    
• • ·080-PA12 Utilising a salutogenic approach to identify resistant behaviours in non-smoking adolescents

    Page :101

    L. King, Clark J. MacLeod

    
• • ·072-PA12 Genetic portrait of smokers with chronic obstructive bronchitis (COB)

    Page :101

    M. Mkheidze, T. Ivtchik, A. Kokosov, A. Freedland, N. Alexandrova, L. Karlova

    
• • ·084-PA12 Smoking habits and attitudes to smoking among hospital employees

    Page :102

    K. Viskum, A-D. Olsen, M. Døssing, U.S. Danielsen

    
• • ·148-PA12 Smoking cessation: diagnostic criteria determine the most effective therapy

    Page :102

    R. Schoberberger, M. Kunze

    
• • ·218-PA12 Evolution des habitudes tabagiques de la population de la wilaya d'Alger de 1984 à 1994

    Page :102

    F. Skander, M. Bellamdani, D. Larbaoui

    
• • ·215-PA12 The prevalence of smoking among patients with cardiovascular and pulmonary diseases

    Page :102

    S. Metsla, L. Praks

    
• • ·234-PA12 Antismoking therapy in active bronchopulmonary tuberculosis

    Page :102-103

    D. Sain, S. Pisarenko

    
• • ·244-PA12 The frequence of smokers and nicotine addiction degree of active smokers with chronic obstructive pulmonary disease

    Page :103

    Lj. Nagorni-Obradovic, M. Mitic-Milikic, V. Bosnjak-Petrovic, V. Stankovic, N. Pajic

    
• • ·247-PA12 Les effets chroniques du narguilé sur l'appareil respiratoire

    Page :103

    Y. Mohammad

    
• • ·259-PA12 Smoking profile of patients admitted to a pulmonary department

    Page :103-104

    V. Petrovic, Lj. Nagorni-Obradovic, S. Radovanovic, A. Ilic, B. Milenkovic

    
• • ·314-PA12 The main features of tobacco smoking and smoking attributable mortality in Hungary. Some results of the health behaviour survey 1994

    Page :104

    P. Józan

    
• • ·357-PA12 Changes in the extent of cigarette smoking among young people at one of the vocational mining schools

    Page :104

    J. Kozielski, J. Szurkowska

    
• • ·365-PA12 Smoking habits among medical students

    Page :104

    E. Kowal, R.M. Mróz, J. Fabczak

    
• • ·036-PA12 Tuberculosis containment and control in a challengingly diverse society

    Page :104-105

    M.I. Winks

    
• • ·037-PA12 Kampo medicine in tuberculosis treatment

    Page :105

    S. Kos, J. Houšková

    
• • ·050-PA12 Tuberculosis control in Kenya — 25 years' experience at Ngaira chest clinic, Nairobi

    Page :105

    R.W. Thuku

    
• • ·059-PA12 Knowledge, attitudes and practices in tuberculosis of health care workers in Cali, Colombia

    Page :105-106

    E. Jaramillo

    
• • ·061-PA12 Knowledge, attitudes and practices of lay people about tuberculosis in Cali, Colombia

    Page :106

    E.B. Jaramillo

    
• • ·086-PA12 A trial on reduction of TB case finding delay in the pilot area in Solomon islands

    Page :106

    E. Imamura, K. Konare, N. Ishikawa

    
• • ·087-PA12 The role of a Japanese public health nurse in TB control activities of JICA/PHC project in Solomon islands

    Page :106

    E. Imamura, M. Hara, N. Ishikawa

    
• • ·154-PA12 Following patients on antituberculous drugs: nurse's call versus physician visit

    Page :106-107

    D.E. Schraufnagel

    
• • ·171-PA12 The role of an area TB co-ordinator

    Page :107

    L.A. Cotton

    
• • ·228-PA12 Nursing management of TB/HIV patients in outpatient TB clinic

    Page :107

    F.K. Leli

    
• • ·248-PA12 Assessment of adherence to preventive chemotherapy — a comparison between MEMS, pill count and urine tests

    Page :107-108

    J.P. Zellweger, C.L. Fallab-Stuby, A. Sauty, C. Uldry, D. Iorillo, M.P. Schneider, M. Bournier

    
• • ·261-PA12 Analysis of pulmonary TB in young adults treated in 1994 at the institute for lung diseases and TB

    Page :108

    N. Bogdanović, A. Mileković, Ž. Uskoković

    
• • ·294-PA12 Combien de temps devons-nous isoler les patients tuberculeux contagieux aprés la mise en route du traitement spécifique?

    Page :108

    M.L. Quinquenel, H. Léna, E. Briens, J.C. Renaud, P.Y. Donnio, B. Desrues, Ph. Delaval

    
• • ·300-PA12 Nursing case management of TB patients in New York City department of health chest clinics

    Page :108-109

    M.S. Dorsinville

    
• • ·398-PA12 The importance of social supports for TB patients to complete treatment

    Page :109

    E. Zack

    
• • ·414-PA12 Nursing in tuberculosis care

    Page :109

    C. Ojiambo

    
• • ·432-PA12 Studies on case finding of tuberculosis patients in national tuberculosis centre (NTC) in Nepal

    Page :109-110

    Y. Nagata, M. Aoki, T. Yamashita

    
• • ·304-PA12 Human tuberculosis caused by Mycobacterium bovis; report of 66 cases

    Page :110

    L.J. González Montaner, E.H. Abbate, M. Di Lonardo, M.I. Medín

    
• • ·419-PA12 Isolation of mycobacteria from Iranian cultured fishes in northern part of Iran

    Page :110

    K. Ghazi-Saidi, F. MajdiNassab, A.A. Velayati, M.R. Masjedi

    
• • ·058-PA12 Tuberculosis control in the caucasus: a priority for WHO

    Page :110

    R. Zalesky, F. Abdullayev, M. Safarian, N. Gogebashvili, M. Grzemaska, J. Theunissen, M. Raviglione

    
• • ·060-PA12 Integration of tuberculosis control program in the primary health care in Cali, Colombia

    Page :110-111

    E.B. Jaramillo

    
• • ·075-PA12 Reshaped national TB program in Hungary

    Page :111

    D. Kozma, G. Pataki, I. Vadász

    
• • ·082-PA12 Tuberculosis control in China

    Page :111

    Min Li Zheng, Jin Duan Mu Hong, Zeng Zhao Feng

    
• • ·083-PA12 Preliminary treatment results of SM(+) pulmonary TB cases treated by intermittent short course chemotherapy (SCC) of Hubei province in 1992–1994

    Page :111-112

    Guanghua Tang, Aiqing Xiao, Qiang Lu

    
• • ·085-PA12 The implementation of a combined TB/Leprosy control programme in Ethiopia: an exercise in management

    Page :112

    P. Saunderson

    
• • ·112-PA12 Tuberculosis training at Alert, Ethiopia

    Page :112

    G. Groenen, M. Asnake, P. Saunderson

    
• • ·126-PA12 Support for the National Tuberculosis & Leprosy Programme in Uganda by German Leprosy Relief Association

    Page :112-113

    H.-U. Wendl-Richter

    
• • ·138-PA12 Etude critique de la méthodologie de l'enquête autour d'un cas de tuberculose en milieu urbain, semi-urbain et tribal dans la Province Sud de la Nouvelle-Calédonie

    Page :113

    F. Droetto, I. Monchotte, M. Noel

    
• • ·147-PA12 Which drugs are used for the treatment of tuberculosis (TB) in Italy? Results of a national survey

    Page :113

    S. Nardini, G.B. Migliori, R. Bertoletti, B. Faravelli, G. Di Pisa

    
• • ·144-PA12 The follow-up of the tuberculous patients at the community tuberculous centers

    Page :113

    K. Cerrahoğlu, R. Aydilek, A. Ilvan, Z. Kartaloğlu, S. Öztürk, E. Kunter

    
• • ·149-PA12 The formal and informal costs of tuberculosis in Sierra Leone

    Page :114

    F. Boillot, N. Gibson

    
• • ·167-PA12 Botusa: a new Epi-Info based software for use with IUATLD/WHO TB registration system

    Page :114

    D. Coulombier, N. Binkin, P. Vranken, D. Rumisha, B. Koosimile, C. Sentle

    
• • ·156-PA12 A trial on acquisition of the high cure rate for TB treatment in Solomon Islands (preliminary report)

    Page :114

    E. Imamura, K. Konare, N. Ishikawa

    
• • ·168-PA12 The new Brazilian model for fighting tuberculosis through science and technology

    Page :114-115

    M.A. Hijjar, E.B. Bahruth, C. Costa Neto

    
• • ·169-PA12 Tuberculosis control in 19 southern districts of Uganda since the implementation of the NTLP

    Page :115

    H.-V. Wendl-Richter, F. Adatu-Engwau

    
• • ·182-PA12 Tuberculosis — an emergency health problem in Europe

    Page :115-116

    J. Leowski

    
• • ·204-PA12 Tuberculosis Programme in the autonomic community of Catalonia (Spain)

    Page :116

    J. Alcaide, I. Parron, M.N. Altet, C. Albiñana, J.L. Taberner, L. Salleras

    
• • ·227-PA12 Short course chemotherapy (SCC) in a pilot district in Nyanza province, Kenya

    Page :116

    M. Olewe

    
• • ·212-PA12 Tuberculosis control programme in China

    Page :116

    Duanmu Hong Jin, Wan Li Ya

    
• • ·221-PA12 Decentralization of TB treatment in Nairobi province

    Page :116

    B. Aluvaala

    
• • ·224-PA12 Comparison of standard and manyatta regimen in Isiolo district of Kenya

    Page :116-117

    J. Kangangi, D. Kibuga

    
• • ·239-PA12 The introduction of short-course chemotherapy in Kenya

    Page :117

    M. Bosman, J. van Gorkom, D. Kibuga

    
• • ·237-PA12 The tuberculosis manyatta project of the NLTP of Kenya: the first decade

    Page :117-118

    M. Bosman, J. van Gorkom, D. Kibuga

    
• • ·240-PA12 Intermittent short-course chemotherapy on ambulatory basis integrated in the primary health care system of the Gambia

    Page :118

    J. Année-van Bavel, M. Bosman, I. Bouchier, K. Manneh

    
• • ·250-PA12 Economic analysis of the tuberculosis control program in Mexico

    Page :118

    J. Rodriguez, L. Yañez

    
• • ·251-PA12 Evaluation of the tuberculosis prevention and control programme of Barcelona after eight years of operation

    Page :119

    H. Galdós, J. Jansá, P. García, J.A. Caylà

    
• • ·271-PA12 Monitoring of tuberculosis treatment of children and adolescents in Poland

    Page :119

    I. Szczuka, J. Masztalerz, M. Miller

    
• • ·283-PA12 Merlin and Tomsk Oblast Co-operative TB project

    Page :119-120

    N. Ignatenko, E. Tayler, C. Mawer

    
• • ·309-PA12 The Namibian tuberculosis association (NAMTA) and its role as a patient interest organization (PIO) in Namibia

    Page :120

    A. Tjerije, M. Rabbow

    
• • ·310-PA12 The need for unique directly observed therapy (DOT) programs targeting TB patients (PTS) in inner cities in developed countries

    Page :120

    W. El-Sadr, F. Medard

    
• • ·322-PA12 Stratégie contre les abandons de traitement anti-tuberculeux. Expérience des centres anti-tuberculeux d'Abidjan, Côte d'Ivoire en 1995

    Page :120-121

    P. Msellati, I.M. Coulibaly, C. Doulhourou, A. Blibolo, M. Peyre, M. Traoré

    
• • ·368-PA12 TB C.P.: Experience in two regions of Ethiopia

    Page :121

    D. Mariani, A. Desta, B. Wolde

    
• • ·420-PA12 Gender and tuberculosis control: a model

    Page :121

    I. Smith

    
• • ·423-PA12 Baseline survey in National Tuberculosis Control Programme in Nepal

    Page :121-122

    T.M. Shakya, R. Komatsu, H. Hoshino, K. Yamakami, J. Kato

    
• • ·440-PA12 L'évolution des indicateurs de suivi du PNT au Tchad de 1992 à 1994

    Page :122

    J.P. Baptiste, E. Morin, P.-Y. Norval

    
• • ·462-PA12 Evaluation des resultats du retraitement des malades tuberculeux au cours des (5) cinq recentes annees de 1989 a 1993 au Benin

    Page :122

    M. Gninafon, S. Anagonou, D. Gazard-Kinde, L. Tawo

    
• • ·456-PA12 Co-operation between the Government of Bangladesh and NGOs in implementing a National Tuberculosis & Leprosy Control Programme

    Page :122

    S. Wust, A. Van Deun

    
• • ·466-PA12 Some considerations concerning tuberculosis control measures in the States of the former USSR and in Eastern Europe

    Page :122-123

    V. Borshchevsky, O. Kalechitz, A. Bogomazova

    
• • ·469-PA12 Changes in the TB programme and treatment outcomes in smear-positive TB patients, Malawi, 1984–1993

    Page :123

    F.M.L. Salaniponi, D.S. Nyangulu

    
• • ·476-PA12 Training for change: Introduction of the National Tuberculosis Control Programme and the re-training of health staff in Egypt

    Page :123

    P.M. Schothorst

    
• • ·090-PA12 Problem of tuberculosis among refugees in Yugoslavia

    Page :123-124

    S. Pavlović, V. Kuruc, Dj. Radaković

    
• • ·129-PA12 Epidemiologic characteristics of tuberculosis in the area of increasing migration of people — the analysis of our material

    Page :124

    Z̆. Ćirić, D. Z̆ivković, I. Stanković, T. Pejčić

    
• • ·164-PA12 Immigration and the resurgence of tuberculosis in the United States

    Page :124

    M. McKenna, E. McCray, I. Onorato

    
• • ·166-PA12 Follow-up of immigrants and refugees radiologically identified as having tuberculosis before entry into United States

    Page :124-125

    P.L.F. Zuber, N.J. Binkin, M.A. Tipple

    
• • ·175-PA12 Incidence rates of tuberculosis in the native and immigrant population in Italy. The Varese study

    Page :125

    G.B. Migliori, A. Spanevello, L. Ballardini, M. Neri, M.L. Moro, L. Trnka, M.C. Raviglione

    
• • ·202-PA12 La tuberculose chez les migrants parmi une population suivie de 1991 à 1995 dans un service de Pneumologie en France

    Page :125

    M.A. Lefebvre, B. Melloni, A. Vergnenègre, X. D'Arco, F. Touraine, B. Eichler, F. Bonnaud

    
• • ·260-PA12 TB among refugees from former SFRJ treated in 1993 at the Institute for Lung Diseases and TB, Belgrade

    Page :125-126

    N. Bogdanovic, A. Milenkovic, G. Mrcic-Martinovic

    
• • ·293-PA12 Results of the screening for tuberculosis among asylum seekers entering the Netherlands in 1993 and 1994

    Page :126

    J.V. Kuyvenhoven

    
• • ·299-PA12 Tuberculosis notifications in England and Wales: potential effects of immigrant cases on mean age of presentation

    Page :126

    P.D.O. Davies, M.A. Bellis, K. Tocque, A. Al-Aidi

    
• • ·328-PA12 Characteristics of immigrants with pulmonary TB

    Page :126-127

    P. Christaki, V. Tsara

    
• • ·341-PA12 Migration control and TBC incidence

    Page :127

    O. Ramis-Juan, C. Moreno, A. Ibañez, J. Mz. Benazet

    
• • ·023-PA12 National survey of TB notifications, 1993; with special reference to the prevalence of HIV sero-positivity

    Page :127

    A.G. Leitch, M. Rubilar, G.I. Forbes, J. Curnow, G. Boyd, S. Burns, B. Watt

    
• • ·053-PA12 Report of 5 HIV-infected tuberculosis patients' treatment

    Page :127-128

    V. Petrenko, S. Kunichkina, A. Poddubny, B. Vengerov

    
• • ·062-PA12 Particularites de l'épidemie VIH/SIDA en Roumanie et ses relations avec la tuberculose

    Page :128

    P. Mihăilescu

    
• • ·064-PA12 Epidemiology of tuberculosis (TB) and AIDS in Rio Grande do Sul (RS) State, Brazil: risk and trends

    Page :128

    C.N. Tietboehl-Filho, R.L. Targa-Ferreira, C.A.A. Espina, P.D. Picon, N.T. Barcellos, R.P. Loureiro

    
• • ·065-PA12 Characteristics of tuberculosis (TB) and AIDS in Rio Grande do Sul State (RS), Brazil: clinical presentation and response to chemotherapy

    Page :128

    C.N. Tietboehl-Filho, R.L. Targa-Ferreira, C.A.A. Espina, P.D. Picon, N.T. Barcellos, R.P. Loureiro

    
• • ·079-PA12 Tuberculosis et VIH à Oran

    Page :128-129

    M.A. Bennani, A. Snouber, M. Guermaz

    
• • ·081-PA12 Pulmonary TB in HIV infected patients (pts)

    Page :129

    M.F. Lidji, A. Hendler, V. Polansky, B. Habot

    
• • ·089-PA12 Increased risk of death in HIV patients with active tuberculosis

    Page :129

    A. Ponticiello, A. Sanduzzi, E. Di Maro, M. Bocchino, S. De Lorenzo, E. Manzillo

    
• • ·106-PA12 Association between TB and HIV infection

    Page :129

    H. Çoçoli, I. Mino

    
• • ·111-PA12 Human alveolar macrophage (HAMS) phagocytosis and oxygen superoxide (O2-) production in AIDS and in healthy subjects

    Page :129-130

    G. Velluti, B. Vecchi, F. Luppi, M.E. Bonucchi, M. Covi

    
• • ·123-PA12 Profil actuel de la tuberculose dans un service de pneumologie Parisien

    Page :130

    J.M. Bréchot, C. Fiscel, J. Rochemaure

    
• • ·132-PA12 Immunodeficiency and sarcoid granuloma formation

    Page :130

    Z. Pavlović-Popović, B. Djurić, V. S̆kodrić

    
• • ·153-PA12 Decreased T-CD4/CD8 lymphocytes in severe cases of tuberculosis

    Page :130

    J.A. Pilheu, M.C. De Salvo, J.D González

    
• • ·163-PA12 Risk of rifampin mono-resistant (RMR) tuberculosis (TB) associated with human immunodeficiency virus (HIV) infection

    Page :130-131

    R. Ridzon, J. Taylor, M. Kelly, S. Valway, L. Geiter, I. Onorato

    
• • ·172-PA12 Bacteriology of consecutively diagnosed HIV+ and HIV− tuberculosis patients in Mwanza, Tanzania

    Page :131

    J. Van Den Broek, A. Mugomela, T. Chonde

    
• • ·173-PA12 Treatment outcome of HIV+ and HIV− tuberculosis patients in Mwanza, Tanzania

    Page :131

    J. Van Den Broek, A. Mugomela, R. O'Brien

    
• • ·177-PA12 Some aspects of pulmonary tuberculosis in AIDS patients

    Page :131-132

    O. Djuric, V. Skodric, Dj. Jevtovic, I. Pesic

    
• • ·183-PA12 Correlation between CD4 number and some clinical aspects in patients coinfected by HIV and TB

    Page :132

    M. Parravicini, S. De Lorenzo, G. Cicchitto, M. Bacchetti, S. Dagasso, P. Viggiani

    
• • ·184-PA12 Association of macrophage activation with increased mortality in HIV-1-positive tuberculosis

    Page :132

    R.S. Wallis, M.S. Helfand, C.C. Whalen, J.L. Johnson, R.D. Mugerwa, M. Vjecha, A. Okwera, J.J. Ellner

    
• • ·186-PA12 Preliminary results of smear positive pulmonary TB and HIV positive patients treated by S.C.C. in Ho Chi Minh City, Vietnam

    Page :132-133

    Tung Le Ba

    
• • ·196-PA12 Surveillance epidémiologique de la tuberculose dans un Service de Référence pour le SIDA à São Paulo, Brésil, 1993/94

    Page :133

    L.F. Jamal, E.A.C. Ruiz, I.A. Guibu, H. Niskier, N.J.S. Santos, M.C. Gianna, A. Grangeiro, A.O. Kalichman

    
• • ·200-PA12 Current HIV seroprevalence rate and occurrence of adverse skin reaction in adults with pulmonary tuberculosis receiving thiacetazone-free anti-TB therapy in Yaoundê, Cameroon

    Page :133

    C. Kuaban, R. Bercion, S. Koulla-Shiro

    
• • ·222-PA12 Rising tuberculosis cases HIV versus programme performance

    Page :133-134

    D.K. Kibuga

    
• • ·235-PA12 Long term risk of TB in contacts of HIV(+) subjects

    Page :134

    M. Espinal, A. Reingold, E. Pérez, L. Henríquez, J. Báez

    
• • ·241-PA12 Thiazina associated severe skin reactions and death reported by the NLTP of Kenya in 1994

    Page :134-135

    M. Bosman, J. van Gorkom, D. Kibuga

    
• • ·252-PA12 HIV influence in the epidemiology of TBC

    Page :135

    J. Caylà, P. Miranda, J.M. Jansà, H. Galdós

    
• • ·272-PA12 Survival of HIV-infected patients after tuberculosis, Bordeaux, France, 1988–1994

    Page :135

    V. Leroy, A. Sentilhes, L.R. Salmi, M. Dupon, J. Texier-Maugein, L. Dequae

    
• • ·274-PA12 Increasing multiple drug resistant tuberculosis (MDRTB) in AIDS patients in Buenos Aires City, Argentina

    Page :135

    E. Abbate, M. Di Lonardo, N. Isola, M. Ambroggi, S. Poggi, A. Rybko, R. Masini, L.J. González Montaner

    
• • ·275-PA12 Preventive therapy for tuberculosis in HIV-infected Ugandans

    Page :135-136

    C. Whalen, P. Nsubuga, J. Johnson, R. Mugerwa, J. Ellner

    
• • ·276-PA12 Predictors of HIV infection in patients presenting with pulmonary tuberculosis in Uganda

    Page :136

    P. Nsubuga, A. Okwera, J. Johnson, R. Mugerwa, J. Ellner, C. Whalen

    
• • ·277-PA12 Reliability of delayed-type hypersensitivity skin testing in HIV-seropositive patients

    Page :136

    D.P. Chin, D. Osmond, K. Page-Shafer, P.C. Hopewell

    
• • ·278-PA12 Incidence of tuberculosis (TB) in injection drug users (IDU) in San Francisco (SF), 1991–1994

    Page :136

    C.L. Daley, J.A. Hahn, P.C. Hopewell, A.R. Moss, G.F. Schecter

    
• • ·289-PA12 Recurrences of tuberculosis in HIV-related patients. Period 1985–1994

    Page :137

    J. Osset, N. Martín-Casabona, P. Bellver, D. Xairó, G. Codina

    
• • ·312-PA12 Etude de la transmission nosocomiale de la tuberculose respiratoire chez des patients séropositifs pour le VIH

    Page :137

    V. Lecerf, V. Berges, E. Bouvet, V. Vincent, D. Decre, B. Regnier

    
• • ·362-PA12 Tuberculin survey in a group of drug users

    Page :137-138

    M. Bugiani, P. Piccioni, E. Caria, L. Forno, M. Cavallero, A. Carosso, W. Arossa

    
• • ·380-PA12 Clinical profile of HIV and TB co-infection on tuberculosis outpatients from health centers of Rio de Janeiro city

    Page :138

    A.S. Toledo, G. Vasconcellos, L.M. Toledo, H. Oliveira, S. Dias, S. Aquino, S. Espirito-Santo, Z. Hartz, O. Berro, P. Sabroza, G. Muzzi de Souza, S. Natal, E. Moreira dos Santos, G. Gerhardt

    
• • ·382-PA12 Prevalence and geographic distribution of HIV infection among outcare tuberculosis patients in Rio de Janeiro

    Page :138

    A.S. Toledo, L.M. Toledo, G. Vasconcellos, H. Oliveira, S. Dias, S. Aquino, S. Espirito-Santo, Z. Hartz, O. Berro, P.R. Martins, P. Sabroza, G. Muzzi de Souza, E. Moreira dos Santos, S. Natal, G. Gerhardt

    
• • ·381-PA12 Trends of tuberculosis morbidity rates in Rio de Janeiro 1981–1994

    Page :138

    L.M. Toledo, A.S. Toledo

    
• • ·383-PA12 Epidemiological and clinical indicators to detect HIV infection among tuberculosis patients

    Page :139

    A.S. Toledo, P.C. Sabroza, L.M. Toledo, G. Vasconcellos, O.J. Berro, H. Oliveira, S. Dias, S. Aquino, S. Espirito-Santo, Z. Hartz, G. Muzzi de Souza, E.M. Santos, S. Natal, G. Gerhardt

    
• • ·405-PA12 Analysis of the intervals between diagnosis of tuberculosis, disseminated MAC disease and AIDS and death in HIV-infected in greater Sao Paulo, Brazil

    Page :139-140

    D.J. Hadad, M.C. Martins, S.Y.M. Ueki, M. Palaci, M.C.A. Palhares, M.T.F. Santos, A.L.N. Placco, C.S.B. Domingues, L.R.M. Marques, A.C. Filho

    
• • ·406-PA12 Prevalence of mycobacterial disease in a population infected with human immunodeficiency virus (HIV) in Greater São Paulo

    Page :140

    D.J. Hadad, M.C.A. Palhares, M.T.F. Santos, A.L.N. Placco, M. Palaci, M.A.S. Telles, L. Ferrazoli, C.S.B. Domingues, L.R.M. Marques, A.C. Filho

    
• • ·407-PA12 Antimicrobial resistance of Mycobacterium tuberculosis (M. tuberculosis) strains isolated from HIV-infected patients in the city of São Paulo (Brazil): predisposing factors

    Page :140-141

    P. Pinto Walkyria, D.J. Hadad, M.C.A. Palhares, A.L.N. Placco, M.T.F. Santos, L. Ferrazoli, M.A.S. Telles, M.C. Martins, S.Y.M. Ueki, M. Palaci

    
• • ·408-PA12 Antimicrobial resistance of Mycobacterium tuberculosis (M. tuberculosis) strains isolated from HIV-infected patients in the city of São Paulo (Brazil): resistance profile

    Page :141

    P. Pinto Walkyria, D.J. Hadad, M.C.A. Palhares, A.L.N. Placco, M.T.F. Santos, L. Ferrazoli, M.A.S. Telles, M.C. Martins, S.Y.M. Ueki, M. Palaci

    
• • ·409-PA12 Clinical evaluation of 205 HIV positive patients with tuberculosis, Sao Paulo, Brazil

    Page :141-142

    D.L. Estevam, R.A. Souza, L. Peron, W.K. Kuen, W.P. Pinto

    
• • ·416-PA12 HIV seroprevalence survey on tuberculosis patients in Kenya

    Page :142

    J. van Gorkom, S. Adallah, J. Adungosi, B. Aluvaala, J. Kangangi, A. Kutwa, M. Olewe, P. Rono, M. Wambua, D. Kibuga

    
• • ·427-PA12 AIDS and tuberculosis in the Republic of Cuba

    Page :142

    E. González, J. Pérez, M. Díaz, J. Valdivia, L. Armas, G. Kourí

    
• • ·447-PA12 Association de tuberculose et SIDA dans un hôpital général de Rio de Janeiro, Brésil

    Page :142-143

    M.K.N. Andrade, O.M. Porto, M.N. Rodrigues, A.C.R. Teixeira, A.R. Navarini, P.H.N. Cezar, G.N. Andrade

    
• • ·450-PA12 Validation of AIDS clinical case-definitions among HIV seropositive patient with tuberculosis (TB) preliminary results

    Page :143

    M.P. Dalcolmo, R.L. Cardoso, A.C.C. Calçado, A.D. Perera, B. Grinzstein, M. Schechter, A.L. Kritski

    
• • ·459-PA12 Serologic study of HIV infection among tuberculosis patients

    Page :143

    A.A. Velayati, M.R. Masjedi, K. Ghazi Saeed, S. KhalilZadeh, N. Baghaii

    
• • ·460-PA12 Clinical features of pulmonary tuberculosis among smear negative patients in East Africa

    Page :143-144

    B. Samb, C.L. Daley, T. Niyongabo, D. Henzel, P. Aubry, B. Larouzé, J. Murray

    
• • ·Use of advanced technology in routine mycobacteriology: quality control and cost benefit aspects

    Page :144

    A.H.J. Kolk, L.F.F. Kox, J. van Leeuwen, S. Kuijper, H.M. Jansen

    
• • ·Newer chemotherapeutic agents for M. tuberculosis and M. avium complex infections

    Page :144

    M.H. Cynamon

    
• • ·Testing of antimycobacterial agents in a macrophage model

    Page :144-145

    L. Heifets

    
• • ·Epidemiological markers for follow up of infections caused by non tuberculous mycobacteria

    Page :145

    V. Vincent

    
• • ·Index

    Page :146-152